Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Boston Scientific exercises option to acquire Farapulse » 07:02 06/24/21 06/24 07:02 06/24/21 07:02 BSX Boston Scientific $43.81 / -0.035 (-0.08%) Boston Scientific… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BSX Boston Scientific $43.81 / -0.035 (-0.08%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary BSX Boston Scientific $43.81 / -0.035 (-0.08%) 06/07/21 Argus Boston Scientific price target raised to $50 from $45 at Argus 05/26/21 Fly Intel: Top five analyst downgrades 05/26/21 Needham Boston Scientific downgraded to Hold at Needham on overextended consensus 05/26/21 Needham Boston Scientific downgraded to Hold from Buy at Needham BSX Boston Scientific $43.81 / -0.035 (-0.08%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open BSX Boston Scientific $43.81 / -0.035 (-0.08%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BSX Boston Scientific $43.81 / -0.035 (-0.08%) 06/21/21 Boston Scientific call buyer realizes 132% same-day gains 06/18/21 Boston Scientific call volume above normal and directionally bullish 05/26/21 Unusually active option classes on open May 26th 05/24/21 Boston Scientific call volume above normal and directionally bullish

Monday
Options	Boston Scientific call buyer realizes 132% same-day gains » 08:00 06/21/21 06/21 08:00 06/21/21 08:00 BSX Boston Scientific $43.02 / -0.32 (-0.74%) Notable profits for the… Notable profits for the buyer who lifted the $0.17 offer for 8,000 Boston Scientific (BSX) Jul-21 47 calls yesterday at 11:27ET when underlying shares were trading at $42.90. Shares closed at $43.02, and the calls at $0.40 for a mark-to-market profit of 132%, or $180K, on the $136K outlay. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BSX Boston Scientific $43.02 / -0.32 (-0.74%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary BSX Boston Scientific $43.02 / -0.32 (-0.74%) 06/07/21 Argus Boston Scientific price target raised to $50 from $45 at Argus 05/26/21 Fly Intel: Top five analyst downgrades 05/26/21 Needham Boston Scientific downgraded to Hold at Needham on overextended consensus 05/26/21 Needham Boston Scientific downgraded to Hold from Buy at Needham BSX Boston Scientific $43.02 / -0.32 (-0.74%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open BSX Boston Scientific $43.02 / -0.32 (-0.74%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BSX Boston Scientific $43.02 / -0.32 (-0.74%) 06/18/21 Boston Scientific call volume above normal and directionally bullish 05/26/21 Unusually active option classes on open May 26th 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish

Friday
Options	Boston Scientific call volume above normal and directionally bullish » 13:05 06/18/21 06/18 13:05 06/18/21 13:05 BSX Boston Scientific $43.17 / -0.17 (-0.39%) Bullish option flow… Bullish option flow detected in Boston Scientific with 14,896 calls trading, 3x expected, and implied vol increasing over 2 points to 23.86%. Jul-21 47 calls and Jul-21 45 calls are the most active options, with total volume in those strikes near 11,800 contracts. The Put/Call Ratio is 0.17. Earnings are expected on July 28th. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BSX Boston Scientific $43.17 / -0.17 (-0.39%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary BSX Boston Scientific $43.17 / -0.17 (-0.39%) 06/07/21 Argus Boston Scientific price target raised to $50 from $45 at Argus 05/26/21 Fly Intel: Top five analyst downgrades 05/26/21 Needham Boston Scientific downgraded to Hold at Needham on overextended consensus 05/26/21 Needham Boston Scientific downgraded to Hold from Buy at Needham BSX Boston Scientific $43.17 / -0.17 (-0.39%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open BSX Boston Scientific $43.17 / -0.17 (-0.39%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BSX Boston Scientific $43.17 / -0.17 (-0.39%) 05/26/21 Unusually active option classes on open May 26th 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish 04/28/21 Boston Scientific call volume above normal and directionally bullish

Over a week ago
Recommendations	Boston Scientific price target raised to $50 from $45 at Argus » 08:07 06/07/21 06/07 08:07 06/07/21 08:07 BSX Boston Scientific $42.04 / +0.69 (+1.67%) Argus analyst Jasper… Argus analyst Jasper Hellweg raised the firm's price target on Boston Scientific to $50 from $45 and keeps a Buy rating on the shares. The analyst cites the company's recent Q1 earnings beat, also noting that the company's sales were stronger in all three of its segments for the first time since Q4 of 2019. The spread of coronavirus vari-nts and the slow pace of vaccinations in some overseas markets may delay a return to full pre-pandemic activity, but Boston Scientific should benefit as more patients return to doctors' offices and other medical facilities as vaccination rates increase and the risk of community transmission diminishes, Hellweg tells investors in a research note. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BSX Boston Scientific $42.04 / +0.69 (+1.67%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary BSX Boston Scientific $42.04 / +0.69 (+1.67%) 05/26/21 Fly Intel: Top five analyst downgrades 05/26/21 Needham Boston Scientific downgraded to Hold at Needham on overextended consensus 05/26/21 Needham Boston Scientific downgraded to Hold from Buy at Needham 05/25/21 Barclays Barclays starts Medical Devices sector with Positive industry view BSX Boston Scientific $42.04 / +0.69 (+1.67%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open BSX Boston Scientific $42.04 / +0.69 (+1.67%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BSX Boston Scientific $42.04 / +0.69 (+1.67%) 05/26/21 Unusually active option classes on open May 26th 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish 04/28/21 Boston Scientific call volume above normal and directionally bullish
Downgrade	Fly Intel: Top five analyst downgrades » 09:55 05/26/21 05/26 09:55 05/26/21 09:55 CCK Crown Holdings $101.84 / -6.31 (-5.83%) , BLL Ball Corp. $82.45 / -3.42 (-3.98%) , ARD Ardagh Group $24.91 / -0.52 (-2.04%) , ITW Illinois Tool Works $230.17 / -2.34 (-1.01%) , AMC AMC Entertainment $17.94 / +1.525 (+9.29%) , BSX Boston Scientific $41.75 / -1.28 (-2.97%) , TVTX Travere Therapeutics $15.18 / -2.6 (-14.62%) Catch up on today's… Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Crown Holdings (CCK), Ball Corp. (BLL) and Ardagh Group (ARD) all downgraded to Market Perform from Outperform at BMO Capital following news that Can-Pack is building a second U.S. beverage can plant in Indiana. 2. Illinois Tool Works (ITW) downgraded to Underweight from Equal Weight at Barclays with analyst Julian Mitchell seeing catalysts to drive a reversal of the stock's recent bounce, including organic sales growth decelerating in most of the company's businesses back to prior peak levels by late 2021, evidence that its share gain efforts are not necessarily gaining traction and the potential levelling off in the "recently-stellar" incremental margins as input cost pressures ratchet higher. 3. AMC Entertainment (AMC) downgraded to Neutral from Buy at B. Riley with analyst Eric Wold saying while he remains confident about a box office recovery into 2022 and 2023 and still sees an opportunity for AMC to gain share, his rating change is based "on valuation only" with a 75% move higher in the shares pushing them above his $16 target. 4. Boston Scientific (BSX) downgraded to Hold from Buy at Needham with analyst Mike Matson contending that consensus estimates for the company's 2022 and 2023 performance look "too high," anticipating downward revisions going into and out of Boston Scientific's investor day in September. 5. Travere Therapeutics (TVTX) downgraded to Neutral from Outperform at Wedbush with analyst Laura Chico noting that Travere announced the FDA did not see interim DUPLEX data as adequate to form the basis for an accelerated approval filing. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TVTX ITW CCK BSX BLL ARD AMC TVTX Travere Therapeutics $15.18 / -2.6 (-14.62%) 05/25/21 Travere gives regulatory update on sparsentan program in FSGS 02/02/21 Ligand says entitled to $5.9M milestone on Travere application submission 01/12/21 Travere Therapeutics receives orphan drug designation for sparsentan from FDA 01/11/21 Travere Therapeutics announces anticipated upcoming milestones ITW Illinois Tool Works $230.17 / -2.34 (-1.01%) 05/07/21 Illinois Tool Works board approves $3B share repurchase program 01/19/21 ITW to acquire MTS test & simulation business from Amphenol 01/19/21 Illinois Tool Works to acquire MTS Test & Simulation business from Amphenol CCK Crown Holdings $101.84 / -6.31 (-5.83%) 04/19/21 Crown Holdings CEO says Q1 performance 'excellent' 04/08/21 Crown to sell 80% European tinplate unit to KPS for EU1.9B 02/25/21 Crown Holdings announces $1.5B share repurchase program 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel BSX Boston Scientific $41.75 / -1.28 (-2.97%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary BLL Ball Corp. $82.45 / -3.42 (-3.98%) 05/20/21 Ball Corp. launches Aluminum Cup at major retailers in all 50 states 04/01/21 Ball Corp. to change ticker symbol on NYSE to 'BALL' from 'BLL' 02/10/21 Ball Aerospace selected to integrate, test Sailcraft for NASA 02/09/21 Ball Aerospace to build spacecraft for NASA heliophysics science mission ARD Ardagh Group $24.91 / -0.52 (-2.04%) 05/17/21 Ardagh Group says it recently experienced cybersecurity incident 02/23/21 Ardagh Metal Packaging to become public through Gores Holdings V combination 02/23/21 Ardagh Group to combine with Gores Holdings V and list on NYSE 02/23/21 Ardagh Group to combine with Gores Holdings V and list on NYSE AMC AMC Entertainment $17.94 / +1.525 (+9.29%) 05/26/21 AMC Entertainment rises 8.8% 05/21/21 AMC Entertainment holder Wanda lowers stake to 0.002% 05/19/21 AMC Entertainment falls -11.2% 05/17/21 AMC Entertainment rises 7.7% CCK BLL ARD ITW AMC BSX TVTX CCK Crown Holdings $101.84 / -6.31 (-5.83%) 05/25/21 BMO Capital Crown Holdings downgraded to Market Perform from Outperform at BMO Capital 05/25/21 Citi Canpack U.S. plant news a negative for Ball and Crown, says Citi 05/25/21 BMO Capital Crown Holdings price target raised to $125 from $120 at BMO Capital 05/20/21 Longbow Crown Holdings initiated with a Buy at Longbow BLL Ball Corp. $82.45 / -3.42 (-3.98%) 05/25/21 BMO Capital Ball Corp. downgraded to Market Perform from Outperform at BMO Capital 05/20/21 Fly Intel: Top five analyst initiations 05/20/21 Longbow Ball Corp. initiated with a Buy at Longbow ARD Ardagh Group $24.91 / -0.52 (-2.04%) 05/25/21 BMO Capital Ardagh Group downgraded to Market Perform from Outperform at BMO Capital 02/25/21 Wells Fargo Ardagh Group upgraded to Overweight from Underweight at Wells Fargo 02/19/21 Barclays Ardagh Group price target raised to $23 from $18 at Barclays 02/17/21 Deutsche Bank Ardagh Group price target raised to $24 from $21 at Deutsche Bank ITW Illinois Tool Works $230.17 / -2.34 (-1.01%) 05/26/21 Barclays Illinois Tool Works downgraded to Underweight from Equal Weight at Barclays 05/05/21 Argus Illinois Tool Works price target raised to $260 from $230 at Argus 05/03/21 Credit Suisse Illinois Tool Works price target raised to $261 from $242 at Credit Suisse 05/03/21 Deutsche Bank Illinois Tool Works price target raised to $227 from $217 at Deutsche Bank AMC AMC Entertainment $17.94 / +1.525 (+9.29%) 05/26/21 B. Riley AMC Entertainment downgraded to Neutral from Buy at B. Riley 05/25/21 Citi Citi boosts AMC target to $3.70, says shares remain overvalued 05/14/21 B. Riley AMC Entertainment price target raised to $16 from $13 at B. Riley 04/16/21 B. Riley AMC CEO update on share issuance a positive, says B. Riley BSX Boston Scientific $41.75 / -1.28 (-2.97%) 05/26/21 Needham Boston Scientific downgraded to Hold at Needham on overextended consensus 05/26/21 Needham Boston Scientific downgraded to Hold from Buy at Needham 05/25/21 Barclays Barclays starts Medical Devices sector with Positive industry view 05/24/21 Barclays Boston Scientific initiated with an Overweight at Barclays TVTX Travere Therapeutics $15.18 / -2.6 (-14.62%) 05/26/21 BMO Capital Travere Therapeutics price target lowered to $33 from $38 at BMO Capital 05/26/21 SVB Leerink Travere Therapeutics price target lowered to $27 from $35 at SVB Leerink 05/26/21 Wedbush Travere Therapeutics downgraded to Neutral at Wedbush on regulatory update 05/26/21 Evercore ISI Travere Therapeutics price target lowered to $23 from $30 at Evercore ISI TVTX ITW CCK BSX BLL ARD AMC TVTX Travere Therapeutics $15.18 / -2.6 (-14.62%) 05/06/21 Travere Therapeutics reports Q1 EPS (96c), consensus (39c) 03/01/21 Travere Therapeutics reports Q4 adjusted EPS ($2.20), consensus (47c) 02/02/21 Travere Therapeutics achieves interim endpoint in Phase 3 DUPLEX study 01/11/21 Travere Therapeutics sees 2020 revenue $199M, consensus $198.61M ITW Illinois Tool Works $230.17 / -2.34 (-1.01%) 04/30/21 Illinois Tool Works raises 2021 EPS view $8.20-$8.60 from $7.60-$8.00 04/30/21 Illinois Tool Works reports Q1 EPS $2.11, consensus $1.90 04/29/21 Notable companies reporting before tomorrow's open CCK Crown Holdings $101.84 / -6.31 (-5.83%) 04/19/21 Crown Holdings backs FY21 adjusted EPS view $6.60-$6.80, consensus $6.86 04/19/21 Crown Holdings sees Q2 adjusted EPS $1.70-$1.80, consensus $1.65 04/19/21 Crown Holdings reports Q1 adjusted EPS $1.83, consensus $1.39 04/19/21 Notable companies reporting after market close BSX Boston Scientific $41.75 / -1.28 (-2.97%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open BLL Ball Corp. $82.45 / -3.42 (-3.98%) 05/06/21 Ball Corp. reports Q1 comparable EPS 72c, consensus 67c 02/04/21 Ball reports Q4 EPS 68c, consensus 78c ARD Ardagh Group $24.91 / -0.52 (-2.04%) 04/29/21 Ardagh Group sees FY21 adjusted EBITDA $1.28B-$1.3B 04/29/21 Ardagh Group sees Q2 adjusted EBITDA $325M-$330M 04/29/21 Ardagh Group reports Q1 adjusted EPS 37c, consensus 37c 02/16/21 Ardagh Group reports Q4 adjusted EPS 28c, consensus 26c AMC AMC Entertainment $17.94 / +1.525 (+9.29%) 05/06/21 AMC Entertainment reports Q1 adjusted EPS ($1.42), consensus ($1.30) 03/10/21 AMC Entertainment reports Q4 EPS ($3.15), consensus ($3.15) 03/10/21 Notable companies reporting after market close 12 Feb CCK BLL AMC CCK Crown Holdings $101.84 / -6.31 (-5.83%) 05/25/21 CANPACK to invest $380M to build second U.S. manufacturing facility, WRTV says 04/01/21 KPS Capital in talks to buy Crown Holdings food can unit for $2B, Bloomberg says 03/31/21 KPS Capital in talks to buy Crown Holdings food can unit for $2B, Bloomberg says 03/10/21 Crown Holdings named a new short Best Idea at Hedgeye, Bloomberg says BLL Ball Corp. $82.45 / -3.42 (-3.98%) 12/14/20 Ball Corp. added as short trade best idea at Hedgeye, Bloomberg says AMC AMC Entertainment $17.94 / +1.525 (+9.29%) 03/23/21 Disney to put 'Black Widow' on Disney+ same day as theaters, Deadline says 03/13/21 Retro stocks suddenly hot, Barron's says 03/12/21 L.A. County officials say movie theaters can reopen Monday, Deadline says 03/10/21 Movie theaters in L.A. could reopen as early as Saturday, CNBC reports TVTX ITW CCK BSX BLL AMC TVTX Travere Therapeutics $15.18 / -2.6 (-14.62%) 05/25/21 Fly Intel: After-Hours Movers ITW Illinois Tool Works $230.17 / -2.34 (-1.01%) 04/30/21 Fly Intel: Pre-market Movers 02/05/21 Fly Intel: Pre-market Movers CCK Crown Holdings $101.84 / -6.31 (-5.83%) 04/19/21 Fly Intel: After-Hours Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/08/21 Fly Intel: After-Hours Movers BSX Boston Scientific $41.75 / -1.28 (-2.97%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BLL Ball Corp. $82.45 / -3.42 (-3.98%) 03/22/21 Fly Insider: Thryv, Abeona among week's notable insider trades AMC AMC Entertainment $17.94 / +1.525 (+9.29%) 05/21/21 Short Interest Report: Aspen Technology short interest hits multiyear high 05/14/21 Short Interest Report: AMC Entertainment shorts sound retreat 05/13/21 Fly Intel: What to watch in Disney earnings report 04/12/21 Fly Insider: Joann, AMC among week's notable insider trades 05/27/21 Crown Holdings Inc. BSX AMC BSX Boston Scientific $41.75 / -1.28 (-2.97%) 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish 04/28/21 Boston Scientific call volume above normal and directionally bullish AMC AMC Entertainment $17.94 / +1.525 (+9.29%) 05/26/21 Unusually active option classes on open May 26th 05/26/21 Notable open interest changes for May 26th 05/26/21 AMC Entertainment call buyer realizes 120% same-day gains 05/25/21 Notable open interest changes for May 25th

Options	Unusually active option classes on open May 26th » 09:40 05/26/21 05/26 09:40 05/26/21 09:40 NBRV Nabriva Therapeutics $1.50 / + (+0.00%) , SIRI Sirius XM $6.00 / + (+0.00%) , EXPR Express $3.95 / + (+0.00%) , BSX Boston Scientific $43.03 / -0.005 (-0.01%) , PDD Pinduoduo $130.83 / +0.02 (+0.02%) , AMC AMC Entertainment $16.41 / -0.005 (-0.03%) , BB BlackBerry $8.59 / + (+0.00%) , GME GameStop $209.31 / + (+0.00%) , F Ford $12.81 / + (+0.00%) , GPS Gap $32.67 / + (+0.00%) Unusual total active… Unusual total active option classes on open include: Nabriva Therapeutics (NBRV), Sirius XM (SIRI), Express (EXPR), Boston Scientific (BSX), Pinduoduo (PDD), AMC Entertainment (AMC), BlackBerry (BB), GameStop (GME), Ford (F), and Gap (GPS). ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SIRI PDD NBRV GPS GME F EXPR BSX BB AMC SIRI Sirius XM $6.00 / + (+0.00%) 05/24/21 Sirius XM, TikTok to create exclusive audio experiences across their platforms 05/11/21 Seth Rogen to launch original podcast series with Sirius XM's Stitcher 05/10/21 SiriusXM, Pandora, Stitcher Advertising organizations unite as SXM Media 04/28/21 Sirius XM reports subscribers at end Q1 were 34.5M, down 1% from last year PDD Pinduoduo $130.83 / +0.02 (+0.02%) 05/26/21 Pinduoduo reports Q1 average monthly active users 724.6M, up 49% y/y 04/30/21 Pinduoduo works to 'deepen' transformation of agriculture 03/17/21 Pinduoduo reports Q4 GMV $255.6B, up 66% y/y 03/17/21 Pinduoduo CEO Chen Lei appointed Chairman NBRV Nabriva Therapeutics $1.50 / + (+0.00%) 05/25/21 Nabriva jumps 28% to nearly $2 after Lefamulin meets primary endpoint in study 05/25/21 Nabriva, Sinovant say Lefamulin met primary endpoint in Phase 3 bridging study 04/15/21 Nabriva announces start of exclusive distribution of Sivextro in U.S. 03/16/21 Nabriva Therapeutics announces publication of analysis of LEAP 2 Phase 3 trial GPS Gap $32.67 / + (+0.00%) 05/11/21 Gap announces resumption of share buyback program 05/04/21 Gap to sell Intermix to Altamont Capital Partners 04/23/21 Athleta announces long-term partnership with Simone Biles 04/20/21 Gap brand Athleta announces entry into Canada GME GameStop $209.31 / + (+0.00%) 05/05/21 S&P upgrades GameStop to 'B' from 'B-,' takes ratings off watch 05/03/21 GameStop to lease 700,000 square foot center in York, Pennsylvania 04/27/21 GameStop up over 7.5% in pre-market after completing at-the-market offering 04/23/21 CEL-SCI recommends itself as next Reddit target ahead of cancer data F Ford $12.81 / + (+0.00%) 05/26/21 Ford expects to have 1M vehicles capable of receiving system updates by year end 05/26/21 Ford establishes Ford Pro, expects $45B in revenue by 2025 05/26/21 Ford expects to spend over $30B on electrification by 2025 05/26/21 Ford establishing 'Ford Pro' vehicle services and distribution business EXPR Express $3.95 / + (+0.00%) 05/18/21 Express rises 10.4% 05/17/21 Express rises 16.7% 03/25/21 Express falls -1.7% 03/24/21 Express falls 6.3% BSX Boston Scientific $43.03 / -0.005 (-0.01%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary BB BlackBerry $8.59 / + (+0.00%) 05/12/21 BlackBerry, University of Waterloo expand partnership 04/27/21 BlackBerry names Tom Eacobacci as COO 04/13/21 BlackBerry and IBM established new partnership 04/07/21 Volvo Group selects BlackBerry QNX for dynamic software platform AMC AMC Entertainment $16.41 / -0.005 (-0.03%) 05/21/21 AMC Entertainment holder Wanda lowers stake to 0.002% 05/19/21 AMC Entertainment falls -11.2% 05/17/21 AMC Entertainment rises 7.7% 05/13/21 AMC Entertainment rises 15.4% NBRV SIRI EXPR BSX PDD AMC BB GME F GPS NBRV Nabriva Therapeutics $1.50 / + (+0.00%) 03/12/21 Northland Nabriva Therapeutics price target lowered to $6 from $9 at Northland 06/22/20 Northland Nabriva Therapeutics price target lowered to $1.50 from $2.50 at Northland SIRI Sirius XM $6.00 / + (+0.00%) 02/03/21 Citi Tax sharing agreement 'very bullish' for Liberty SiriusXM, says Citi 01/28/21 Fly Intel: Top five analyst downgrades 01/28/21 Credit Suisse Sirius XM downgraded to Neutral after rally at Credit Suisse 01/27/21 Credit Suisse Sirius XM downgraded to Neutral from Outperform at Credit Suisse EXPR Express $3.95 / + (+0.00%) 03/11/21 B. Riley Express price target raised to $3.50 from $1.50 at B. Riley Securities 01/15/21 B. Riley Express price target raised to $1.50 from $1 at B. Riley Securities BSX Boston Scientific $43.03 / -0.005 (-0.01%) 05/26/21 Needham Boston Scientific downgraded to Hold at Needham on overextended consensus 05/26/21 Needham Boston Scientific downgraded to Hold from Buy at Needham 05/25/21 Barclays Barclays starts Medical Devices sector with Positive industry view 05/24/21 Barclays Boston Scientific initiated with an Overweight at Barclays PDD Pinduoduo $130.83 / +0.02 (+0.02%) 05/05/21 Daiwa Pinduoduo initiated with a Buy at Daiwa 04/20/21 China Renaissance Pinduoduo downgraded to Hold from Buy at China Renaissance 03/18/21 Fly Intel: Top five analyst downgrades 03/18/21 Benchmark Pinduoduo price target raised to $176 from $150 at Benchmark AMC AMC Entertainment $16.41 / -0.005 (-0.03%) 05/26/21 B. Riley AMC Entertainment downgraded to Neutral from Buy at B. Riley 05/25/21 Citi Citi boosts AMC target to $3.70, says shares remain overvalued 05/14/21 B. Riley AMC Entertainment price target raised to $16 from $13 at B. Riley 04/16/21 B. Riley AMC CEO update on share issuance a positive, says B. Riley BB BlackBerry $8.59 / + (+0.00%) 03/31/21 Fly Intel: Top five analyst upgrades 03/31/21 Canaccord BlackBerry upgraded to Hold from Sell at Canaccord 02/16/21 Fly Intel: Top five analyst downgrades 02/16/21 Canaccord BlackBerry cut to Sell after 'targeted short squeeze' at Canaccord GME GameStop $209.31 / + (+0.00%) 04/12/21 Fly Intel: Top five analyst downgrades 04/12/21 Ascendiant GameStop downgraded to Sell from Hold at Ascendiant 04/06/21 BofA BofA keeps $10 target on GameStop despite 'positive' funding news 04/05/21 Telsey Advisory Telsey keeps Underperform rating on GameStop after Q1 update, ATM program bump F Ford $12.81 / + (+0.00%) 05/25/21 Goldman Sachs Lordstown Motors price target lowered to $8 from $10 at Goldman Sachs 05/21/21 Morgan Stanley Morgan Stanley says F-150 Lightning priced lower, coming sooner than expected 05/20/21 Wolfe Research Wolfe downgrades Lordstown to sell with $1 target after Ford reveal 05/18/21 Tudor Pickering Tudor Pickering starts Ford at Buy on EBIT margin improvement GPS Gap $32.67 / + (+0.00%) 05/25/21 Morgan Stanley Gap price target raised to $33 ahead of earnings at Morgan Stanley 05/18/21 Fly Intel: Top five analyst upgrades 05/18/21 Credit Suisse Gap upgraded to Neutral from Underperform at Credit Suisse 05/18/21 UBS Gap price target raised to $38 from $28 at UBS SIRI PDD GPS GME F EXPR BSX BB AMC SIRI Sirius XM $6.00 / + (+0.00%) 04/28/21 Sirius XM backs FY21 revenue view $8.35B, consensus $8.4B 04/28/21 Sirius XM reports Q1 EPS ex-items 7c, consensus 6c 04/27/21 Notable companies reporting before tomorrow's open PDD Pinduoduo $130.83 / +0.02 (+0.02%) 05/26/21 Pinduoduo reports Q1 adjusted EPS (23c), consensus (42c) 03/17/21 Pinduoduo reports Q4 EPS (2c), consensus 1c 03/17/21 Pinduoduo reports Q4 EPS (2c), consensus 1c 03/16/21 Notable companies reporting before tomorrow's open GPS Gap $32.67 / + (+0.00%) 03/04/21 Gap sees FY21 EPS $1.20-$1.35, consensus $1.28 03/04/21 Gap reports Q4 EPS 61c, consensus 18c 03/04/21 Notable companies reporting after market close GME GameStop $209.31 / + (+0.00%) 04/05/21 GameStop reports preliminary sales QTD up about 9% y/y 03/23/21 GameStop reports Q4 adjusted EPS $1.34, consensus $1.35 03/23/21 Notable companies reporting after market close 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) F Ford $12.81 / + (+0.00%) 04/28/21 Ford reports Q1 adjusted EPS 89c, consensus 21c 04/28/21 Notable companies reporting after market close 03/16/21 Ford backs FY21 guidance, says results could be hurt if semi shortage extends 02/04/21 Ford reports Q4 adjusted EPS 34c, consensus (7c) EXPR Express $3.95 / + (+0.00%) 03/10/21 Express sees sequential sales improvement throughout 2021 03/10/21 Express reports Q4 adjusted EPS (66c), consensus (82c) 12/03/20 Express reports Q3 adjusted EPS ($1.17), consensus (51c) BSX Boston Scientific $43.03 / -0.005 (-0.01%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c BB BlackBerry $8.59 / + (+0.00%) 03/30/21 BlackBerry reports Q4 adjusted EPS 3c, consensus 3c 12/17/20 BlackBerry reports Q3 adjusted EPS 2c, consensus (1c) AMC AMC Entertainment $16.41 / -0.005 (-0.03%) 05/06/21 AMC Entertainment reports Q1 adjusted EPS ($1.42), consensus ($1.30) 03/10/21 AMC Entertainment reports Q4 EPS ($3.15), consensus ($3.15) 03/10/21 Notable companies reporting after market close 11 Dec 18 Nov SIRI PDD GPS GME F EXPR BB AMC SIRI Sirius XM $6.00 / + (+0.00%) 01/15/21 Apple to challenge Spotify with podcast subscription service, Information says PDD Pinduoduo $130.83 / +0.02 (+0.02%) 05/18/21 Biden to delay revamp of Trump blacklist for China investments, Bloomberg says 05/06/21 Biden likely to proceed with Trump's China investment ban, Bloomberg says 05/06/21 Biden likely to preserve limits on U.S. investments in China, Bloomberg says 02/21/21 Alibaba, Pinduoduo join fight against looming China food crisis, Bloomberg says GPS Gap $32.67 / + (+0.00%) 04/13/21 Barclays to replace Synchrony as Gap's credit-card issuer, WSJ reports 03/08/21 Gap mulling options, including possible sale, for China business, Bloomberg says 03/08/21 Gap said to consider sale of China business, Bloomberg says 03/05/21 Gap CEO sees 'peacocking effect' as people emerge from Covid, WSJ reports GME GameStop $209.31 / + (+0.00%) 05/21/21 Netflix looking to hire to expand in video games, The Information says 04/28/21 Robinhood faces surge of customer service complaints, WSJ reports 04/15/21 Einhorn says Palihapitiya, Musk fueled GameStop frenzy, Reuters says 04/12/21 GameStop seeks new CEO amid pivot to e-commerce, Reuters reports F Ford $12.81 / + (+0.00%) 05/25/21 Ford plans to develop two dedicated all-electric vehicle platforms, Reuters says 05/21/21 Ford took 20,000 reservations for electric F-150 in first 12 hours, CNBC reports 05/20/21 Ford considering divesting electric scooter unit Spin, Bloomberg reports 05/20/21 Ford weighs sale or spinoff of electric-scooter unit Spin, Bloomberg says EXPR Express $3.95 / + (+0.00%) 02/01/21 Robinhood in talks with lenders to raise $1B in debt, Reuters reports BB BlackBerry $8.59 / + (+0.00%) 02/11/21 Startup developing new devices to be sold under BlackBerry brand, Nikkei says 01/15/21 BlackBerry reports settlement with Facebook over patents, Bloomberg says AMC AMC Entertainment $16.41 / -0.005 (-0.03%) 03/23/21 Disney to put 'Black Widow' on Disney+ same day as theaters, Deadline says 03/13/21 Retro stocks suddenly hot, Barron's says 03/12/21 L.A. County officials say movie theaters can reopen Monday, Deadline says 03/10/21 Movie theaters in L.A. could reopen as early as Saturday, CNBC reports SIRI PDD NBRV GPS GME F EXPR BSX BB AMC SIRI Sirius XM $6.00 / + (+0.00%) 04/28/21 Fly Intel: Pre-market Movers 02/02/21 Fly Intel: Pre-market Movers 01/27/21 Fly Intel: What to watch in Apple earnings report 01/15/21 Fly Intel: Wall Street's top stories for Friday PDD Pinduoduo $130.83 / +0.02 (+0.02%) 03/18/21 ViacomCBS, Pinduoduo downgrades among today's top calls on Wall Street 03/17/21 Fly Intel: Pre-market Movers 01/26/21 Comcast upgrade, Bed Bath & Beyond downgrade among top calls on Wall Street NBRV Nabriva Therapeutics $1.50 / + (+0.00%) 05/26/21 Fly Intel: Pre-market Movers 12/10/20 Fly Intel: After-Hours Movers GPS Gap $32.67 / + (+0.00%) 05/18/21 Gap, Snowflake upgrades among today's top calls on Wall Street 05/04/21 Fly Intel: Wall Street's top stories for Tuesday 03/04/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street GME GameStop $209.31 / + (+0.00%) 05/05/21 Fly Intel: Wall Street's top stories for Wednesday 04/27/21 Game On: Discord reportedly ends takeover talks with Microsoft 04/24/21 Short Interest Report: Position in Fisker, MicroVision highest of 2021 04/19/21 Fly Intel: Wall Street's top stories for Monday F Ford $12.81 / + (+0.00%) 05/25/21 Fly Intel: Wall Street's top stories for Tuesday 05/25/21 Investors abandon RIDE as Lordstown seeks cash, slashes targets 05/24/21 Charged: Lordstown Motors in spotlight after Ford electric F-150 reveal EXPR Express $3.95 / + (+0.00%) 02/01/21 Fly Intel: Wall Street's top stories for Monday 02/01/21 Square Cash App seen emerging as biggest winner from 'Robinhood drama' 02/01/21 Fly Intel: Wall Street's top stories at midday 01/28/21 Fly Intel: After-Hours Movers BSX Boston Scientific $43.03 / -0.005 (-0.01%) 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BB BlackBerry $8.59 / + (+0.00%) 03/31/21 Fly Intel: Pre-market Movers 03/30/21 Fly Intel: After-Hours Movers 02/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/02/21 Fly Intel: Wall Street's top stories at midday AMC AMC Entertainment $16.41 / -0.005 (-0.03%) 05/21/21 Short Interest Report: Aspen Technology short interest hits multiyear high 05/14/21 Short Interest Report: AMC Entertainment shorts sound retreat 05/13/21 Fly Intel: What to watch in Disney earnings report 04/12/21 Fly Insider: Joann, AMC among week's notable insider trades 05/27/21 Digital Media 05/26/21 Pinduoduo - PDD 05/27/21 Gap - GPS 06/03/21 Express - EXPR 07/27/21 Sirius XM - SIRI 05/26/21 Ford 06/03/21 SIRIUS XM Radio Inc 06/09/21 Express, Inc. 06/09/21 GameStop Corp. 06/21/21 Sirius XM SIRI PDD NBRV GPS GME F EXPR BSX BB AMC SIRI Sirius XM $6.00 / + (+0.00%) 05/24/21 Sirius XM call volume above normal and directionally bullish 05/24/21 Unusually active option classes on open May 24th 05/18/21 Sirius XM call volume above normal and directionally bullish 04/19/21 Sirius XM call volume above normal and directionally bullish PDD Pinduoduo $130.83 / +0.02 (+0.02%) 05/25/21 Unusually active option classes on open May 25th 05/11/21 Pinduoduo call volume above normal and directionally bullish 05/10/21 Pinduoduo put volume heavy and directionally bearish 04/06/21 Pinduoduo call volume above normal and directionally bullish NBRV Nabriva Therapeutics $1.50 / + (+0.00%) 03/22/21 Largest borrow rate increases among liquid names GPS Gap $32.67 / + (+0.00%) 05/20/21 Straddle buyer in Gap Stores looking for 1-day $1 move 05/14/21 Early notable gainers among liquid option names on May 14th 05/03/21 Gap call volume above normal and directionally bullish 05/03/21 Early notable gainers among liquid option names on May 3rd GME GameStop $209.31 / + (+0.00%) 03/23/21 GameStop options imply 45.0% move in share price post-earnings 03/12/21 Notable open interest changes for March 12th 03/11/21 Notable open interest changes for March 11th 03/11/21 Largest borrow rate increases among liquid names F Ford $12.81 / + (+0.00%) 05/24/21 Notable open interest changes for May 24th 05/24/21 Ford call buyer realizes 24% same-day gains EXPR Express $3.95 / + (+0.00%) 03/18/21 Express call volume above normal and directionally bullish 03/15/21 Express call volume above normal and directionally bullish 03/15/21 Unusually active option classes on open March 15th BSX Boston Scientific $43.03 / -0.005 (-0.01%) 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish 04/28/21 Boston Scientific call volume above normal and directionally bullish 04/20/21 Boston Scientific call volume above normal and directionally bullish BB BlackBerry $8.59 / + (+0.00%) 05/13/21 BlackBerry call volume above normal and directionally bullish 04/28/21 BlackBerry call volume above normal and directionally bullish 04/27/21 BlackBerry call volume above normal and directionally bullish 04/22/21 BlackBerry call volume above normal and directionally bullish AMC AMC Entertainment $16.41 / -0.005 (-0.03%) 05/26/21 Notable open interest changes for May 26th 05/26/21 AMC Entertainment call buyer realizes 120% same-day gains 05/25/21 Notable open interest changes for May 25th 05/19/21 Notable open interest changes for May 19th
Downgrade	Boston Scientific downgraded to Hold at Needham on overextended consensus » 07:20 05/26/21 05/26 07:20 05/26/21 07:20 BSX Boston Scientific $43.03 / +0.215 (+0.50%) , ABT Abbott $118.43 / +1.13 (+0.96%) As previously reported,… As previously reported, Needham analyst Mike Matson downgraded Boston Scientific (BSX) to Hold from Buy. The analyst contends that consensus estimates for the company's 2022 and 2023 performance look "too high", anticipating downward revisions going into and out of Boston Scientific's investor day in September. Matson adds that Abbott's (ABT) upcoming Amulet left atrial appendage closure device launch could cause Boston Scientific's WATCHMAN growth to slow, and he sees the company's annual operating margin improvement close to 50bps than 100bps. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BSX ABT BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary ABT Abbott $118.43 / +1.13 (+0.96%) 05/21/21 United Airlines to expand service to Europe as Italy, Spain re-open to tourists 05/17/21 Abbott receives CE Mark for TAVI system 05/13/21 FDA says Abbott recalls Assurity and Endurity pacemakers 05/06/21 Abbott begins trial for combined atrial fibrillation and heart failure treatment BSX ABT BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/26/21 Needham Boston Scientific downgraded to Hold from Buy at Needham 05/25/21 Barclays Barclays starts Medical Devices sector with Positive industry view 05/24/21 Barclays Boston Scientific initiated with an Overweight at Barclays 05/06/21 Raymond James Abiomed could face new competition from Boston Scientific, says Raymond James ABT Abbott $118.43 / +1.13 (+0.96%) 05/24/21 Barclays Abbott initiated with an Overweight at Barclays 04/29/21 Wells Fargo Boston Scientific price target raised to $50 from $42 at Wells Fargo 04/15/21 Atlantic Equities Atlantic Equities starts Abbott at Neutral BSX ABT BSX Boston Scientific $43.03 / +0.215 (+0.50%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open ABT Abbott $118.43 / +1.13 (+0.96%) 04/20/21 Abbott sees FY21 adjusted cont ops EPS 'at least' $5.00, consensus $5.04 04/20/21 Abbott reports Q1 adjusted EPS $1.32, consensus $1.27 04/19/21 Notable companies reporting before tomorrow's open ABT ABT Abbott $118.43 / +1.13 (+0.96%) 05/04/21 Glucose monitor gaining traction in sports, tech groups, WSJ reports 03/16/21 Abbott confirms to Bloomberg suspension of trial enrollment BSX ABT BSX Boston Scientific $43.03 / +0.215 (+0.50%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday ABT Abbott $118.43 / +1.13 (+0.96%) 04/20/21 Fly Intel: Pre-market Movers 03/08/21 Fly Insider: Wayfair, Affirm among week's notable insider trades 01/27/21 Fly Intel: Wall Street's top stories at midday 01/27/21 Fly Intel: Pre-market Movers BSX ABT BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish 04/28/21 Boston Scientific call volume above normal and directionally bullish 04/20/21 Boston Scientific call volume above normal and directionally bullish ABT Abbott $118.43 / +1.13 (+0.96%) 04/20/21 Unusually active option classes on open April 20th 01/28/21 Early notable gainers among liquid option names on January 28th
Downgrade	Boston Scientific downgraded to Hold from Buy at Needham » 05:29 05/26/21 05/26 05:29 05/26/21 05:29 BSX Boston Scientific $43.03 / +0.215 (+0.50%) Needham analyst Mike… Needham analyst Mike Matson downgraded Boston Scientific to Hold from Buy without a price target. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/25/21 Barclays Barclays starts Medical Devices sector with Positive industry view 05/24/21 Barclays Boston Scientific initiated with an Overweight at Barclays 05/06/21 Raymond James Abiomed could face new competition from Boston Scientific, says Raymond James 04/29/21 Truist Boston Scientific price target raised to $50 from $42 at Truist BSX Boston Scientific $43.03 / +0.215 (+0.50%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open BSX Boston Scientific $43.03 / +0.215 (+0.50%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish 04/28/21 Boston Scientific call volume above normal and directionally bullish 04/20/21 Boston Scientific call volume above normal and directionally bullish
Conference/Events	UBS to hold a virtual conference » 04:55 05/26/21 05/26 04:55 05/26/21 04:55 NBTX Nanobiotix $16.16 / + (+0.00%) , MRNA Moderna $169.25 / +5.16 (+3.14%) , TELA Tela Bio $13.85 / +0.6 (+4.53%) , ICLR Icon $229.34 / -2.74 (-1.18%) , AMWL Amwell $11.89 / +0.38 (+3.30%) , BRKR Bruker $69.86 / +0.12 (+0.17%) , SIOX Sio Gene Therapies $2.22 / +0.01 (+0.45%) , BMRN BioMarin $77.60 / +0.08 (+0.10%) , NVS Novartis $88.51 / +0.51 (+0.58%) , TERN Terns Pharmaceuticals $15.39 / -0.62 (-3.87%) , EAR Eargo $32.10 / -1.12 (-3.37%) , JAZZ Jazz Pharmaceuticals $177.71 / -1.17 (-0.65%) , TNDM TNDM / + , BAYRY Bayer $16.93 / -0.265 (-1.54%) , ANIK Anika Therapeutics $43.66 / -0.55 (-1.24%) , CVAC CureVac $115.64 / +1.27 (+1.11%) , BSX Boston Scientific $43.03 / +0.215 (+0.50%) , APLT Applied Therapeutics $18.57 / +1.06 (+6.05%) , ARVN Arvinas $65.15 / -0.78 (-1.18%) , PACB Pacific Biosciences $25.68 / -0.1 (-0.39%) , ABBV AbbVie $114.56 / -1.35 (-1.16%) , ZYXI Zynex $14.12 / -0.61 (-4.14%) , BAX Baxter $82.34 / -0.42 (-0.51%) , KOD Kodiak Sciences $82.62 / +1.66 (+2.05%) , ARWR Arrowhead $73.96 / -0.83 (-1.11%) , CUTR Cutera $36.98 / -1.15 (-3.02%) , TVTY Tivity Health $25.73 / -0.09 (-0.35%) , PTCT PTC Therapeutics $39.66 / +0.52 (+1.33%) , CTLT Catalent $103.45 / +0.88 (+0.86%) , RHHBY Roche $43.57 / + (+0.00%) , CLPT ClearPoint Neuro $18.07 / -0.38 (-2.06%) , BNTX BioNTech $197.53 / +2.64 (+1.35%) , ALGN Align Technology $594.91 / -9.47 (-1.57%) , DBTX Decibel Therapeutics $7.85 / -0.205 (-2.55%) Global Healthcare Virtual… Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZYXI TVTY TNDM TERN TELA SIOX RHHBY PTCT PACB NVS NBTX MRNA KOD JAZZ ICLR DBTX CVAC CUTR CTLT CLPT BSX BRKR BNTX BMRN BAYRY BAX ARWR ARVN APLT AMWL ALGN ABBV ZYXI Zynex $14.12 / -0.61 (-4.14%) 04/09/21 Zynex announces new corporate headquarters 03/08/21 Zynex announces $10M share repurchase program 01/14/21 Zynex announces filing of patent for noninvasive sepsis monitor 01/06/21 Zynex obtains second U.S. Utility patent for Blood Volume Monitor Device. TVTY Tivity Health $25.73 / -0.09 (-0.35%) 04/14/21 Tivity Health appoints new Information and Experience and Innovation officers TNDM TNDM / + 03/17/21 Tandem Diabetes director Blickenstaff sells more than $17M in shares 03/17/21 Tandem Diabetes director Blickenstaff sells more than $17M in shares TERN Terns Pharmaceuticals $15.39 / -0.62 (-3.87%) 03/22/21 Terns Pharmaceuticals initiates dosing in Phase 1 trial of TERN-501 03/08/21 Terns to report data from Phase 2a LIFT study of TERN-101 in 3Q21 TELA Tela Bio $13.85 / +0.6 (+4.53%) 05/25/21 Tela Bio appoints Marissa Conrad as VP, clinical and regulatory affairs 05/19/21 Tela Bio initiates BRAVO II study of OviTEX 03/18/21 Tela Bio announces 12-month analysis from BRAVO study of OviTex 01/05/21 Tela Bio appoints Bruce Freedman as VP, clinical development SIOX Sio Gene Therapies $2.22 / +0.01 (+0.45%) 05/13/21 Sio Gene Therapies announces data from clinical trial studying AXO-AAV-GM1 03/15/21 Sio Gene Therapies had $120.9M in cash, equivalents at March 12 02/09/21 Sio Gene Therapies expects cash to sustain operations into 2Q22 02/04/21 Sio Gene Therapies receives $11.6M from sale of Arvelle Therapeutics RHHBY Roche $43.57 / + (+0.00%) 05/25/21 Pieris announces respiratory and ophthalmology collaboration with Genentech 05/25/21 Roche announces European Commission approves Venclyxto-based combinations 05/19/21 Genentech announces interim results from Phase III IMpower010 study PTCT PTC Therapeutics $39.66 / +0.52 (+1.33%) 04/15/21 PTC Therapeutics announces FIREFISH trial results at AAN virtual meeting 04/01/21 PTC Therapeutics to receive $20M commercial milestone payment from Roche 03/30/21 Roche announces European Commission approval of Evrysdi 03/30/21 PTC Therapeutics granted marketing authorization for Evrysdi from EC PACB Pacific Biosciences $25.68 / -0.1 (-0.39%) 04/26/21 Pacific Biosciences launches HiFi Sequencing and Software v10.1 release 03/30/21 FTC challenges Illumina's proposed acquisition of cancer detection test maker 02/24/21 Children's Mercy Kansas City implements four PacBio Sequel IIe Systems 02/18/21 Pacific Biosciences announces LabCorp's addition of PacBio Sequel II Systems NVS Novartis $88.51 / +0.51 (+0.58%) 05/18/21 Novartis' Sandoz to invest EUR150M in new antibiotics manufacturing technology 05/17/21 U.S. Supreme Court denies Sandoz petition to review biosimilar Erelzi case 05/03/21 Novartis reports Phase 3 KESTREL and KITE studies met primary endpoints 05/03/21 Novartis confirms clinical development plans for biosimilar aflibercept NBTX Nanobiotix $16.16 / + (+0.00%) 01/28/21 Nanobiotix doses first patient with NBTXR3 in Esophageal Cancer 01/25/21 Nanobiotix to partner with Sanofi on gene therapy pipeline 01/15/21 Nanobiotix announces first results from NBTXR3 study MRNA Moderna $169.25 / +5.16 (+3.14%) 05/25/21 Moderna TeenCOVE study of its COVID vaccine in adolescents meets endpoint 05/23/21 Moderna, Samsung Biologics announce manufacturing agreement of COVID vaccine 05/22/21 Moderna signs memoranda of understandings with South Korea 05/21/21 Moderna announces MFDS authorization of COVID-19 vaccine KOD Kodiak Sciences $82.62 / +1.66 (+2.05%) 03/26/21 Kronos Bio appoints Taiyin Yang to board of directors 02/14/21 Kodiak Sciences announces data from ongoing Phase 1b study of KSI-301 JAZZ Jazz Pharmaceuticals $177.71 / -1.17 (-0.65%) 04/23/21 GW Pharmaceuticals shareholders approve acquisition by Jazz Pharmaceuticals 04/20/21 Jazz Pharma announces results from Phase 3 study of XywavTM oral solution 04/12/21 Jazz Pharmaceuticals: FDA grants Priority Review of sNDA for Xywav 04/01/21 Lava Therapeutics appoints Karen Wilson to board of directors ICLR Icon $229.34 / -2.74 (-1.18%) 05/03/21 Achilles Therapeutics appoints O'Neill to board of directors, Velders to SAB 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/16/21 Icon provided update on its CYTO-200 portfolio of clinical programs DBTX Decibel Therapeutics $7.85 / -0.205 (-2.55%) 03/22/21 Decibel Therapeutics added to Russell 2000 Index 02/24/21 Decibel Therapeutics presents preclinical findings on DB-OTO CVAC CureVac $115.64 / +1.27 (+1.11%) 05/13/21 CureVac, GSK announce rat model data for second COVID-19 vaccine candidate 04/15/21 CureVac provides business update, Covid-19 progress 03/22/21 CureVac expands CVnCoV Covid-19 vaccine candidate clinical trial analyses 03/04/21 CureVac and Novartis in initial pact on Covid vaccine candidate CUTR Cutera $36.98 / -1.15 (-3.02%) 05/19/21 Cutera director Plants acquires over 600,000 common shares 05/05/21 Cutera COO Jason Richey to step down 02/17/21 Cutera not providing formal guidance at this time CTLT Catalent $103.45 / +0.88 (+0.86%) 05/11/21 Catalent names Thomas Castellano as CFO 04/06/21 Moderna, Catalent expand collaboration to dedicate new COVID-19 vaccine line 02/16/21 Moderna provides supply update for U.S. COVID-19 vaccines 02/02/21 Catalent reports Q2 adjusted EPS 63c, consensus 55c CLPT ClearPoint Neuro $18.07 / -0.38 (-2.06%) 05/10/21 ClearPoint Neuro to partner with D&K Engineering on robotic system development 03/24/21 ClearPoint Neuro announces Ellisa Cholapranee as General Counsel 02/18/21 ClearPoint Neuro, Philips enter license and research agreement for Maestro 02/11/21 ClearPoint, Blackrock Microsystems in development pact with option agreement BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/25/21 Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary BRKR Bruker $69.86 / +0.12 (+0.17%) 05/13/21 Bruker announces two year $500M repurchase pact 01/11/21 Seer, Bruker sign commercial agreement for unbiased, deep proteomics 01/04/21 Bruker announces FDA clearance, U.S. launch of MBT Sepsityper Kit US IVD 12/18/20 Bruker launches FluoroType SARS-CoV-2/Flu/RSV PCR panel BNTX BioNTech $197.53 / +2.64 (+1.35%) 05/24/21 Pfizer initiates study exploring coadminstration of 20vPNC candidate 05/20/21 Pfizer and BioNTech to supply Turkey with 60 million doses of COVID-19 vaccine 05/20/21 BioNTech, Pfizer to supply EU with up to 1.8B additional COVID-19 vaccine doses 05/19/21 FDA clears thawed Pfizer, BioNTech COVID vaccine to be stored for up to 1 month BMRN BioMarin $77.60 / +0.08 (+0.10%) 05/24/21 BioMarin granted accelerated assessment of Valoctocogene Roxaparvovec by EMA 05/19/21 BioMarin provides update of Phase 1/2 study of hemophilia A candidate 04/28/21 BioMarin partners with The Allen Institute 03/21/21 BioMarin announces data from long-term extension Phase 3 vosoritide study BAYRY Bayer $16.93 / -0.265 (-1.54%) 05/14/21 Fears Nachawati law firm says appellate ruling deals 'blow' to Bayer efforts 05/14/21 California appeals court upholds $25M verdict against Bayer's Monsanto 05/12/21 Bayer confirms outlook provided in February 05/03/21 Bayer's copanlisib granted FDA orphan designation BAX Baxter $82.34 / -0.42 (-0.51%) 05/25/21 Baxter announce global launch of PrisMax 2 05/03/21 Baxter raises quarterly dividend 14% to 28c from 24.5c per share 04/21/21 Baxter gets grant from German Federal Ministry of Education and Research 03/12/21 Baxter announces FDA clearance of Artificial Kidney 98 ARWR Arrowhead $73.96 / -0.83 (-1.11%) 05/18/21 Arrowhead earns $10M option exercise fee 04/28/21 Arrowhead announces improvement in fibrosis after ARO-AAT treatment in Patients 04/15/21 Arrowhead announces ARO-DUX4 as muscle targeted RNAi candidate 03/01/21 Arrowhead files IND to start study of ARO-APOC3 to treat hypertriglyceridemia ARVN Arvinas $65.15 / -0.78 (-1.18%) 03/01/21 Arvinas announces anticipated milestones, expectations 03/01/21 Arvinas expects cash to fund operating expenses into 2024 12/14/20 Arvinas announces anticipated milestones 12/14/20 Arvinas releases interim clinical data on ARV-110 APLT Applied Therapeutics $18.57 / +1.06 (+6.05%) 02/01/21 Applied Therapeutics restarts pediatric galactosemia study 12/09/20 Applied Therapeutics launches Galactosemia awareness, education initiative 12/09/20 Applied Therapeutics announces MRS data from ACTION-Galactosemia study AMWL Amwell $11.89 / +0.38 (+3.30%) 05/13/21 Amwell falls -15.5% 03/25/21 Amwell falls -14.5% 01/27/21 American Well Corp trading resumes 01/27/21 American Well Corp trading halted, volatility trading pause ALGN Align Technology $594.91 / -9.47 (-1.57%) 05/24/21 Align Technology CFO sells 6.9K shares of common stock 05/18/21 Align Technology announces $100M accelerated stock repurchase program 05/03/21 Align Technology announces $100M accelerated stock repurhase program 04/28/21 Align Technology and DECA extend pact ABBV AbbVie $114.56 / -1.35 (-1.16%) 05/25/21 AbbVie announces new European approval for VENCLYXTO combination 05/24/21 AbbVie analyses show risankizumab achieves clinical remission in study 05/24/21 AbbVie Phase 3 Rinvoq data published in The Lancet 05/18/21 U.S. House committee chairs call on FTC to launch inquiry of AbbVie's Humira NBTX MRNA TELA ICLR AMWL BRKR SIOX BMRN NVS TERN EAR JAZZ TNDM BAYRY ANIK CVAC BSX APLT ARVN PACB ABBV ZYXI BAX KOD ARWR CUTR TVTY PTCT CTLT RHHBY CLPT BNTX ALGN DBTX NBTX Nanobiotix $16.16 / + (+0.00%) 01/05/21 Evercore ISI Nanobiotix initiated with an Outperform at Evercore ISI 01/05/21 UBS Nanobiotix initiated with a Buy at UBS MRNA Moderna $169.25 / +5.16 (+3.14%) 05/21/21 Piper Sandler Piper says overseas approvals providing 'second leg of growth' for Moderna 05/07/21 Barclays Moderna price target raised to $194 from $178 at Barclays 05/07/21 Goldman Sachs Moderna price target raised to $228 from $206 at Goldman Sachs 05/06/21 Piper Sandler Moderna price target lowered to $231 from $234 at Piper Sandler TELA Tela Bio $13.85 / +0.6 (+4.53%) 04/12/21 Piper Sandler Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 03/25/21 Canaccord Tela Bio pieces in place for accelerating growth, says Canaccord 01/14/21 Piper Sandler Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss ICLR Icon $229.34 / -2.74 (-1.18%) 05/10/21 Truist PRA Health downgraded to Hold from Buy at Truist 05/03/21 Mizuho Icon price target raised to $242 from $217 at Mizuho 04/29/21 Credit Suisse Icon price target raised to $245 from $240 at Credit Suisse 04/20/21 Baird PRA Health downgraded to Neutral from Outperform at Baird AMWL Amwell $11.89 / +0.38 (+3.30%) 05/17/21 Guggenheim Amwell upgraded to Buy from Neutral at Guggenheim 05/13/21 Piper Sandler Amwell price target lowered to $20 from $30 at Piper Sandler 05/04/21 Piper Sandler Teladoc closed down 5% on three year old 'news,' says Piper Sandler 05/03/21 Cantor Fitzgerald Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald BRKR Bruker $69.86 / +0.12 (+0.17%) 05/06/21 BTIG Bruker price target raised to $80 from $73 at BTIG 05/06/21 SVB Leerink Bruker price target raised to $80 from $70 at SVB Leerink 02/17/21 Stifel Bruker price target raised to $65 from $48 at Stifel 02/17/21 Citi Bruker price target raised to $65 from $57 at Citi SIOX Sio Gene Therapies $2.22 / +0.01 (+0.45%) 04/30/21 Fly Intel: Top five analyst initiations 04/30/21 H.C. Wainwright Sio Gene Therapies initiated with a Buy at H.C. Wainwright BMRN BioMarin $77.60 / +0.08 (+0.10%) 04/30/21 Wedbush BioMarin's Q1 revenue was better than expected, says Wedbush 04/26/21 Credit Suisse BioMarin assumed with an Outperform at Credit Suisse 03/04/21 Guggenheim BioMarin assumed at Buy from Neutral at Guggenheim 03/01/21 Evercore ISI BioMarin upgraded to Outperform from In Line at Evercore ISI NVS Novartis $88.51 / +0.51 (+0.58%) 05/11/21 Morgan Stanley Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley 04/28/21 JPMorgan Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan 04/28/21 Oddo BHF Novartis upgraded to Outperform from Neutral at Oddo BHF 04/19/21 UBS Novartis price target raised to CHF 96 from CHF 95 at UBS TERN Terns Pharmaceuticals $15.39 / -0.62 (-3.87%) 03/02/21 Cowen Terns initiated with Outperform on NASH potential at Cowen 03/02/21 JPMorgan Terns Pharmaceuticals initiated with an Overweight at JPMorgan 03/02/21 Cowen Terns Pharmaceuticals initiated with an Outperform at Cowen 03/02/21 Goldman Sachs Terns Pharmaceuticals initiated with a Buy at Goldman Sachs EAR Eargo $32.10 / -1.12 (-3.37%) 05/13/21 Wells Fargo Eargo price target lowered to $52 from $68 at Wells Fargo 05/12/21 JPMorgan JPMorgan sees four 'compelling' MedTech opportunities after selloff 01/13/21 Wells Fargo Eargo price target raised to $60 from $53 at Wells Fargo 11/10/20 Fly Intel: Top five analyst initiations JAZZ Jazz Pharmaceuticals $177.71 / -1.17 (-0.65%) 05/19/21 Fly Intel: Top five analyst initiations 05/19/21 JPMorgan Jazz Pharmaceuticals resumed with an Overweight at JPMorgan 05/17/21 H.C. Wainwright Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright 04/21/21 Cantor Fitzgerald Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald TNDM TNDM / + 05/25/21 Barclays Barclays starts Medical Devices sector with Positive industry view 05/24/21 Barclays Tandem Diabetes initiated with an Underweight at Barclays 05/06/21 SVB Leerink Tandem Diabetes price target raised to $102 from $95 at SVB Leerink 05/06/21 Oppenheimer Tandem Diabetes price target raised to $135 from $130 at Oppenheimer BAYRY Bayer $16.93 / -0.265 (-1.54%) 05/19/21 Morgan Stanley Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley 05/19/21 JPMorgan JPMorgan upgrades Bayer to Overweight with earnings at 'turning point' 05/18/21 JPMorgan Bayer upgraded to Overweight from Neutral at JPMorgan 05/14/21 Berenberg Bayer price target raised to EUR 74 from EUR 68 at Berenberg ANIK Anika Therapeutics $43.66 / -0.55 (-1.24%) 12/16/20 Barrington Anika Therapeutics upgraded to Outperform with $43 target at Barrington 12/16/20 Barrington Anika Therapeutics upgraded to Outperform from Market Perform at Barrington CVAC CureVac $115.64 / +1.27 (+1.11%) 04/26/21 Credit Suisse CureVac assumed with an Underperform at Credit Suisse 04/26/21 Guggenheim CureVac initiated with a Buy at Guggenheim 01/07/21 Morgan Stanley CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley 12/10/20 Credit Suisse CureVac downgraded to Underperform on rising valuation at Credit Suisse BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/24/21 Barclays Boston Scientific initiated with an Overweight at Barclays 05/06/21 Raymond James Abiomed could face new competition from Boston Scientific, says Raymond James 04/29/21 Truist Boston Scientific price target raised to $50 from $42 at Truist APLT Applied Therapeutics $18.57 / +1.06 (+6.05%) 11/17/20 Barclays Applied Therapeutics price target lowered to $44 from $64 at Barclays 10/08/20 Truist Applied Therapeutics initiated with a Buy at Truist 10/08/20 Truist Applied Therapeutics initiated with a Buy at Truist ARVN Arvinas $65.15 / -0.78 (-1.18%) 05/20/21 UBS Arvinas initiated with a Buy at UBS 04/21/21 Truist Truist starts Arvinas with a Buy on PROTACs potential 04/21/21 Truist Arvinas initiated with a Buy at Truist 03/31/21 BMO Capital Arvinas initiated with an Outperform at BMO Capital PACB Pacific Biosciences $25.68 / -0.1 (-0.39%) 03/31/21 Piper Sandler Illumina should be bought on weakness from FTC challenge, says Piper Sandler 02/11/21 Cantor Fitzgerald Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald 02/11/21 Piper Sandler Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler 01/15/21 Piper Sandler Pacific Biosciences price target raised to $20 from $12 at Piper Sandler ABBV AbbVie $114.56 / -1.35 (-1.16%) 05/19/21 Piper Sandler Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs 05/13/21 Cantor Fitzgerald Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald 05/11/21 Maxim Soliton downgraded to Hold from Buy at Maxim 05/03/21 Mizuho AbbVie price target raised to $128 from $126 at Mizuho ZYXI Zynex $14.12 / -0.61 (-4.14%) 04/29/21 Piper Sandler Zynex price target lowered to $15 from $19 at Piper Sandler 03/09/21 Northland Zynex upgraded to Outperform from Market Perform at Northland 02/26/21 B. Riley B. Riley downgrades Zynex to Neutral on 'deteriorating profitability' 02/26/21 B. Riley Zynex downgraded to Neutral from Buy at B. Riley Securities BAX Baxter $82.34 / -0.42 (-0.51%) 05/24/21 Barclays Baxter initiated with an Equal Weight at Barclays 04/30/21 Citi Baxter price target raised to $98 from $94 at Citi 04/29/21 Piper Sandler Baxter price target raised to $85 from $80 at Piper Sandler KOD Kodiak Sciences $82.62 / +1.66 (+2.05%) 05/11/21 Roth Capital Roth Capital upgrades Kodiak Sciences to Buy on recent selloff 05/11/21 Roth Capital Kodiak Sciences upgraded to Buy from Neutral at Roth Capital 05/11/21 BMO Capital Kodiak Sciences price target lowered to $104 from $138 at BMO Capital 05/11/21 Barclays Kodiak Sciences price target lowered to $86 from $90 at Barclays ARWR Arrowhead $73.96 / -0.83 (-1.11%) 02/08/21 B. Riley Arrowhead price target raised to $106 from $98 at B. Riley Securities 02/08/21 Citi Arrowhead price target raised to $110 from $90 at Citi 02/05/21 Chardan Arrowhead price target raised to $97 from $81 at Chardan 02/05/21 H.C. Wainwright Arrowhead price target raised to $95 from $90 at H.C. Wainwright CUTR Cutera $36.98 / -1.15 (-3.02%) 03/05/21 Piper Sandler Cutera price target raised to $42 from $38 at Piper Sandler 02/18/21 Piper Sandler Cutera price target raised to $38 from $28 at Piper Sandler 11/05/20 Piper Sandler Cutera price target raised to $28 from $22 at Piper Sandler 09/14/20 Stephens Cutera price target raised to $24 from $18 at Stephens TVTY Tivity Health $25.73 / -0.09 (-0.35%) 02/25/21 Barrington Tivity Health price target raised to $32 from $28 at Barrington 02/25/21 Piper Sandler Tivity Health price target raised to $27 from $16 at Piper Sandler 01/15/21 Credit Suisse Tivity Health downgraded to Underperform with $19 target at Credit Suisse 01/15/21 Credit Suisse Tivity Health downgraded to Underperform from Neutral at Credit Suisse PTCT PTC Therapeutics $39.66 / +0.52 (+1.33%) 05/17/21 Truist PTC Therapeutics price target lowered to $65 from $75 at Truist 04/26/21 Credit Suisse PTC Therapeutics assumed with a Neutral at Credit Suisse 03/29/21 RBC Capital PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation 03/29/21 RBC Capital PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital CTLT Catalent $103.45 / +0.88 (+0.86%) 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/02/21 Argus Catalent price target raised to $140 from $130 at Argus 02/03/21 UBS Catalent price target raised to $135 from $115 at UBS 02/03/21 RBC Capital Catalent price target raised to $137 from $125 at RBC Capital RHHBY Roche $43.57 / + (+0.00%) 05/05/21 BTIG Mereo BioPharma initiated with a Buy at BTIG 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/25/21 Wedbush iTeos Therapeutics price target raised to $52 from $46 at Wedbush CLPT ClearPoint Neuro $18.07 / -0.38 (-2.06%) 03/18/21 Lake Street Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential 03/18/21 Lake Street ClearPoint Neuro initiated with a Buy at Lake Street 02/22/21 B. Riley ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities 01/22/21 B. Riley ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities BNTX BioNTech $197.53 / +2.64 (+1.35%) 05/18/21 Fly Intel: Top five analyst initiations 05/18/21 Goldman Sachs BioNTech initiated with a Neutral at Goldman Sachs 05/12/21 Canaccord BioNTech price target raised to $240 from $130 at Canaccord 05/11/21 Fly Intel: Top five analyst downgrades ALGN Align Technology $594.91 / -9.47 (-1.57%) 04/29/21 SVB Leerink Align Technology price target raised to $770 from $690 at SVB Leerink 04/29/21 Credit Suisse Align Technology price target raised to $715 from $693 at Credit Suisse 04/29/21 Stifel Align Technology price target raised to $750 from $650 at Stifel 04/29/21 Baird Align Technology price target raised to $745 from $655 at Baird DBTX Decibel Therapeutics $7.85 / -0.205 (-2.55%) 03/09/21 Citi Decibel Therapeutics initiated with a Buy at Citi 03/09/21 SVB Leerink Decibel Therapeutics initiated with an Outperform at SVB Leerink 03/09/21 Barclays Decibel Therapeutics initiated with an Overweight at Barclays 03/09/21 BMO Capital Decibel Therapeutics initiated with an Outperform at BMO Capital ZYXI TVTY TNDM TELA SIOX RHHBY PTCT PACB NVS MRNA KOD JAZZ ICLR EAR CUTR CTLT BSX BRKR BNTX BMRN BAYRY BAX ARWR ARVN APLT AMWL ALGN ABBV ZYXI Zynex $14.12 / -0.61 (-4.14%) 04/29/21 Zynex sees FY21 revenue $135M-$150M, consensus $138.59M 04/29/21 Zynex sees Q2 revenue $31M-$32.5M, consensus $31.43M 04/29/21 Zynex reports Q1 GAAP EPS (2c), consensus (3c) 04/12/21 Zynex sees FY21 revenue $135M-$150M, consensus $138.03M TVTY Tivity Health $25.73 / -0.09 (-0.35%) 05/05/21 Tivity Health narrows FY21 adjusted EPS view to $1.49-$1.56 from $1.47-$1.56 05/05/21 Tivity Health reports Q1 adjusted EPS 40c, consensus 33c 02/24/21 Tivity Health sees FY21 adjusted EPS $1.47-$1.56, consensus $1.36 02/24/21 Tivity Health reports Q4 adjusted EPS 38c, consensus 29c TNDM TNDM / + 05/05/21 Tandem Diabetes sees FY21 revenue $625M-$640M, consensus $610.52M 05/05/21 Tandem Diabetes reports Q1 EPS (8c), consensus (16c) TELA Tela Bio $13.85 / +0.6 (+4.53%) 01/14/21 Tela Bio sees 2020 revenue $18M-$18.2M, consensus $18.55M 01/14/21 Tela Bio sees Q4 revenue $5.5M-$5.7M, consensus $6.01M SIOX Sio Gene Therapies $2.22 / +0.01 (+0.45%) 02/09/21 Sio Gene Therapies reports Q3 EPS (20c), consensus (29c) RHHBY Roche $43.57 / + (+0.00%) 04/21/21 Roche reports Q1 group sales CHF 14.93B vs. CHF 15.14B last year 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year PTCT PTC Therapeutics $39.66 / +0.52 (+1.33%) 05/04/21 PTC Therapeutics reports Q1 EPS ($1.83), consensus ($1.51) 02/25/21 PTC Therapeutics reports Q4 EPS ($1.08), consensus (94c) PACB Pacific Biosciences $25.68 / -0.1 (-0.39%) 04/29/21 Pacific Biosciences reports Q1 EPS (45c), consensus (46c) 01/11/21 Pacific Biosciences sees Q4 revenue $27M, consensus $23.69M NVS Novartis $88.51 / +0.51 (+0.58%) 04/27/21 Novartis sees FY21 core operating income to grow mid single digit percentage 04/27/21 Novartis reports Q1 core EPS $1.52, consensus $1.59 01/26/21 Novartis sees 2021 core operating income to grow mid single digit 01/26/21 Novartis reports Q4 core EPS $1.34, consensus $1.36 MRNA Moderna $169.25 / +5.16 (+3.14%) 05/06/21 Moderna reports Q1 EPS $2.84, consensus $2.39 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open KOD Kodiak Sciences $82.62 / +1.66 (+2.05%) 05/10/21 Kodiak Sciences reports Q1 EPS (98c), consensus (97c) 03/01/21 Kodiak Sciences reports Q4 EPS (97c), consensus (80c) JAZZ Jazz Pharmaceuticals $177.71 / -1.17 (-0.65%) 05/04/21 Jazz Pharmaceuticals backs FY21 adjusted EPS view $15.65-$16.85 05/04/21 Jazz Pharmaceuticals reports Q1 EPS $3.92, consensus $3.71 02/23/21 Jazz Pharmaceuticals sees FY21 adjusted EPS $15.65-$16.85, consensus $16.78 02/23/21 Jazz Pharmaceuticals reports Q4 EPS $4.00, consensus $4.20 ICLR Icon $229.34 / -2.74 (-1.18%) 04/28/21 Icon raises Fy21 EPS view to $8.40-$8.80 from $8.10-$8.50, consensus $8.25 04/28/21 Icon reports Q1 EPS $2.06, consensus $1.97 02/24/21 Icon sees FY21 adjusted EPS $8.10-$8.50, consensus $7.94 02/24/21 Icon reports Q4 adjusted EPS $1.90, consensus $1.83 EAR Eargo $32.10 / -1.12 (-3.37%) 02/25/21 Eargo sees FY21 revenue $87M-$93M, consensus $87.73M 02/25/21 Eargo reports Q4 EPS (30c), consensus (21c) 01/11/21 Eargo sees FY20 revenue approximately $69M, consensus $64.63M 01/11/21 Eargo sees Q4 revenue $22.2M, consensus $17.78M CUTR Cutera $36.98 / -1.15 (-3.02%) 05/05/21 Cutera not issuing full-year guidance 05/05/21 Cutera reports Q1 EPS (2c), consensus (10c) 02/17/21 Cutera reports Q4 EPS 12c, consensus 4c CTLT Catalent $103.45 / +0.88 (+0.86%) 05/04/21 Catalent raises FY21 revenue view to $3.875B-$3.975B from $3.8B-$3.95B 05/04/21 Catalent reports Q3 adjusted EPS 82c, consensus 74c 05/03/21 Notable companies reporting before tomorrow's open BSX Boston Scientific $43.03 / +0.215 (+0.50%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open BRKR Bruker $69.86 / +0.12 (+0.17%) 05/05/21 Bruker raises FY21 EPS view to $1.82-$1.87 from $1.72-$1.77, consensus $1.82 05/05/21 Bruker reports Q1 EPS 44c, consensus 32c 04/13/21 Bruker sees Q1 revenue $549M-$554M, consensus $506.86M 02/16/21 Bruker sees FY 21 EPS $1.72-$1.77, consensus $1.71 BNTX BioNTech $197.53 / +2.64 (+1.35%) 05/10/21 BioNTech reports Q1 EPS EUR 4.39 vs. (EUR 0.24) last year BMRN BioMarin $77.60 / +0.08 (+0.10%) 04/29/21 BioMarin backs FY21 revenue view $1.75B-$1.85B, consensus $1.81B 04/29/21 BioMarin reports Q1 EPS 9c, consensus (10c) 02/25/21 BioMarin sees FY21 revenue $1.75B-$1.85B, consensus $1.91B 02/25/21 BioMarin reports Q4 EPS 12c, consensus (19c) BAYRY Bayer $16.93 / -0.265 (-1.54%) 05/12/21 Bayer reports Q1 core EPS EUR2.59 vs. EUR2.67 last year 02/25/21 Bayer sees 2021 core EPS approx. EUR5.60-EUR5.80 02/25/21 Bayer reports Q4 core EPS EUR1.32 vs. EUR1.44 last year BAX Baxter $82.34 / -0.42 (-0.51%) 04/29/21 Baxter raises FY21 adjusted EPS view to $3.47-$3.55 from $3.35-$3.43 04/29/21 Baxter sees Q2 adjusted EPS 72c-75c, consensus 78c 04/29/21 Baxter reports Q1 adjusted EPS 76c, consensus 65c 04/28/21 Notable companies reporting before tomorrow's open ARWR Arrowhead $73.96 / -0.83 (-1.11%) 05/04/21 Arrowhead reports Q2 EPS (26c), consensus (13c) 02/04/21 Arrowhead reports Q1 EPS (20c) vs. (3c) last year ARVN Arvinas $65.15 / -0.78 (-1.18%) 05/04/21 Arvinas reports Q1 EPS (84c), consensus (82c) 03/01/21 Arvinas reports Q4 EPS (99c), consensus (78c) APLT Applied Therapeutics $18.57 / +1.06 (+6.05%) 05/11/21 Applied Therapeutics reports Q1 EPS ($1.00), consensus ($1.01) 03/18/21 Applied Therapeutics reports 2020 EPS ($4.28), consensus ($4.53) AMWL Amwell $11.89 / +0.38 (+3.30%) 05/12/21 Amwell sees FY21 revenue $260M-$270M, consensus $266.21M 05/12/21 Amwell reports Q1 EPS (16c), consensus (19c) 03/24/21 Amwell reports Q4 revenue $60.4M, consensus $54M 03/24/21 Notable companies reporting after market close ALGN Align Technology $594.91 / -9.47 (-1.57%) 04/28/21 Align Technology reports Q1 EPS $2.49, consensus $2.02 02/03/21 Align Technology reports Q4 EPS $2.61, consensus $2.14 02/03/21 Align Technology reports Q4 EPS $2.61, consensus $2.14 02/03/21 Notable companies reporting after market close ABBV AbbVie $114.56 / -1.35 (-1.16%) 04/30/21 AbbVie sees Q2 adjusted EPS $3.05-$3.09, consensus $3.06 04/30/21 AbbVie sees FY21 revenue approaching $55.9B, consensus $55.34B 04/30/21 AbbVie raises FY21 adjusted EPS view to $12.37-$12.57 from $12.32-$12.52 04/30/21 AbbVie reports Q1 adjusted EPS $2.95, consensus $2.83 19 Feb 12 Feb 12 Feb 05 Feb 28 Jan 15 Jan 16 Dec 11 Dec 23 Nov 18 Nov 11 Nov 21 Oct 16 Oct 17 Sep 12 Aug 14 Aug 23 Jul 15 Jul 26 Jun 11 Jun RHHBY PACB NVS MRNA JAZZ ICLR CVAC CTLT BNTX BMRN BAYRY BAX ARWR ABBV RHHBY Roche $43.57 / + (+0.00%) 03/20/21 Still reasons to be hopeful about Lilly, Biogen Alzheimer's drugs, Barron's says 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports PACB Pacific Biosciences $25.68 / -0.1 (-0.39%) 02/23/21 Sources claim Softbank plans 'billions' in investment in biotech, Bloomberg says 02/10/21 SoftBank to invest $900M in Pacific Biosciences, WSJ reports 01/08/21 SoftBank has taken 6% stake in Pacific Biosciences, Bloomberg reports 01/08/21 Pacific Biosciences jumps after Bloomberg says SoftBank takes 6% stake NVS Novartis $88.51 / +0.51 (+0.58%) 03/15/21 BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says MRNA Moderna $169.25 / +5.16 (+3.14%) 05/24/21 Moderna and Aldevron expand mRNA vaccine and therapeutic pipeline 05/17/21 Biden to announce U.S. will send 20M COVID-19 vaccine doses abroad, CNBC says 05/16/21 COVID drugmakers sponsoring ads on TV, social media, WSJ reports 05/11/21 Takeda may double Moderna imports to hasten Japan vaccination, Reuters reports JAZZ Jazz Pharmaceuticals $177.71 / -1.17 (-0.65%) 04/05/21 'Failure is the new winning' for Jazz Pharmaceuticals, FFJ says ICLR Icon $229.34 / -2.74 (-1.18%) 04/15/21 Syneos could be CRO 'target still standing when music stops,' Dealreporter says CVAC CureVac $115.64 / +1.27 (+1.11%) 05/06/21 Germany's Merkel opposed to vaccine patent waivers, Bloomberg reports 05/06/21 Merkel opposes plan to waive COVID vaccine patent protection, Bloomberg says 03/08/21 Tesla, CureVac create printer for COVID-19 vaccines, Tesmanian reports CTLT Catalent $103.45 / +0.88 (+0.86%) 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/24/21 AstraZeneca says 29M doses in Italy set for EU, poor countries, Reuters says 03/23/21 Catalent gets U.S. approval to make J&J COVID vaccine, Bloomberg reports 03/23/21 Catalent said to get FDA approval to make J&J COVID vaccine, Bloomberg reports BNTX BioNTech $197.53 / +2.64 (+1.35%) 05/20/21 BioNTech chief says vaccine 70%-75% effective for India variant, Reuters reports 05/13/21 Pfizer got no response from Brazil on vaccine offers last year, Reuters says 05/12/21 CDC panel backs Pfizer-BioNTech vaccine use for children aged 12 to 15 BMRN BioMarin $77.60 / +0.08 (+0.10%) 02/02/21 Amicus, BioMarin speculated by Dealreporter as possible Vertex targets BAYRY Bayer $16.93 / -0.265 (-1.54%) 04/22/21 Roundup lawyers call Bayer legal strategy 'pay-to-appeal scheme,' Bloomberg says 03/30/21 Bayer to soon launch sale of pest control unit worth over EUR2B, Reuters reports 03/26/21 Bayer's Monsanto, Nuziveedu settle IP dispute, Reuters reports 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says BAX Baxter $82.34 / -0.42 (-0.51%) 03/11/21 Omnicell rumored to receive sweetened bid from Baxter, blog report claims 12/09/20 Baxter willing to pay over $125 per share for Omnicell, CNBC reports 12/09/20 Baxter not willing to go hostile to acquire Omnicell, CNBC reports 12/09/20 Omnicell board rejected Baxter takeover bid, CNBC reports ARWR Arrowhead $73.96 / -0.83 (-1.11%) 01/25/21 Arrowhead files IND for study of ARO-ANG3 for treatment of mixed dyslipidemia 01/25/21 Arrowhead files IND for study of ARO-ANG3 for treatment of mixed dyslipidemia ABBV AbbVie $114.56 / -1.35 (-1.16%) 04/20/21 California lawyer accuses drugmakers of causing opioid addiction, WSJ reports 03/15/21 AbbVie in discussions to sell $5B women's drug portfolio, Reuters reports 12/16/20 AbbVie unit wins ITC trade secret case against Evolus, Bloomberg says 12/16/20 AbbVie unit wins ITC trade secret case against Evolus, Bloomberg says TERN SIOX RHHBY PTCT NVS NBTX MRNA JAZZ ICLR DBTX CVAC CTLT CLPT BSX BRKR BNTX BMRN BAYRY BAX ARWR ARVN APLT AMWL ALGN ABBV TERN Terns Pharmaceuticals $15.39 / -0.62 (-3.87%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech SIOX Sio Gene Therapies $2.22 / +0.01 (+0.45%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/16/20 Fly Intel: Pre-market Movers RHHBY Roche $43.57 / + (+0.00%) 03/23/21 Fly Intel: Wall Street's top stories at midday PTCT PTC Therapeutics $39.66 / +0.52 (+1.33%) 03/23/21 Ionis Pharmaceuticals slides as Wall Street digests HD program setback NVS Novartis $88.51 / +0.51 (+0.58%) 05/18/21 Before the Move: Watch Allogene ahead of ALLO-501 update 03/10/21 Novartis downgrade, HP Enterprise upgrade among today's top calls on Wall Street 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday NBTX Nanobiotix $16.16 / + (+0.00%) 01/25/21 Fly Intel: After-Hours Movers MRNA Moderna $169.25 / +5.16 (+3.14%) 05/25/21 Fly Intel: Wall Street's top stories for Tuesday 05/25/21 Fly Intel: Wall Street's top stories at midday 05/25/21 Fly Intel: Pre-market Movers 05/24/21 Fly Intel: Pre-market Movers JAZZ Jazz Pharmaceuticals $177.71 / -1.17 (-0.65%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday ICLR Icon $229.34 / -2.74 (-1.18%) 02/24/21 Fly Intel: Pre-market Movers DBTX Decibel Therapeutics $7.85 / -0.205 (-2.55%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts CVAC CureVac $115.64 / +1.27 (+1.11%) 05/06/21 Moderna, Pfizer slip despite stronger results as U.S. backs vaccine IP waiver 03/04/21 Fly Intel: Pre-market Movers CTLT Catalent $103.45 / +0.88 (+0.86%) 05/04/21 Fly Intel: Pre-market Movers 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/06/21 Fly Intel: Wall Street's top stories at midday 03/23/21 Fly Intel: Wall Street's top stories for Tuesday CLPT ClearPoint Neuro $18.07 / -0.38 (-2.06%) 02/19/21 Fly Intel: Pre-market Movers BSX Boston Scientific $43.03 / +0.215 (+0.50%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BRKR Bruker $69.86 / +0.12 (+0.17%) 04/13/21 Fly Intel: After-Hours Movers BNTX BioNTech $197.53 / +2.64 (+1.35%) 05/12/21 Fly Intel: Wall Street's top stories for Wednesday 05/11/21 Fly Intel: Wall Street's top stories for Tuesday 05/11/21 Fly Intel: Wall Street's top stories at midday BMRN BioMarin $77.60 / +0.08 (+0.10%) 02/25/21 Fly Intel: After-Hours Movers BAYRY Bayer $16.93 / -0.265 (-1.54%) 01/07/21 Fly Intel: Pre-market Movers BAX Baxter $82.34 / -0.42 (-0.51%) 12/09/20 Fly Intel: Wall Street's top stories for Wednesday 12/09/20 Fly Intel: Wall Street's top stories at midday ARWR Arrowhead $73.96 / -0.83 (-1.11%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades ARVN Arvinas $65.15 / -0.78 (-1.18%) 12/15/20 Fly Intel: Wall Street's top stories for Tuesday 12/15/20 Fly Intel: Wall Street's top stories at midday 12/14/20 Fly Intel: Wall Street's top stories for Monday 12/14/20 Fly Intel: Wall Street's top stories at midday APLT Applied Therapeutics $18.57 / +1.06 (+6.05%) 02/22/21 Fly Insider: Corvus, ALJ Regional Holdings among week's notable insider trades AMWL Amwell $11.89 / +0.38 (+3.30%) 05/13/21 Fly Intel: Wall Street's top stories for Thursday 05/13/21 Fly Intel: Wall Street's top stories at midday 03/25/21 Fly Intel: Pre-market Movers 03/17/21 Teladoc under pressure as Amazon announces virtual care expansion plans ALGN Align Technology $594.91 / -9.47 (-1.57%) 04/28/21 Fly Intel: After-Hours Movers 02/03/21 Fly Intel: After-Hours Movers ABBV AbbVie $114.56 / -1.35 (-1.16%) 05/10/21 Fly Intel: Wall Street's top stories for Monday 05/10/21 Fly Intel: Wall Street's top stories at midday 04/30/21 Fly Intel: Wall Street's top stories for Friday 04/30/21 Fly Intel: Wall Street's top stories at midday 05/26/21 Global Healthcare Virtual Conference 2021 06/08/21 ClearPoint Neuro - CLPT 08/09/21 BioNTech - BNTX 08/12/21 PDFUA Date for Xywav 08/20/21 PDUFA Date for Vosoritide 06/02/21 TELA Bio, Inc. 06/03/21 Anika Therapeutics Inc 06/03/21 Applied Therapeutics, Inc. 06/03/21 ClearPoint Neuro Inc 06/04/21 Bruker Corporation 06/07/21 Kodiak Sciences Inc. 06/08/21 Arvinas, Inc. 06/08/21 PTC Therapeutics, Inc. 06/15/21 American Well Corp. 06/15/21 Cutera Inc 06/16/21 Anika Therapeutics Inc 06/16/21 Pacific Biosciences of California Inc ZYXI SIOX PACB MRNA EAR CVAC CLPT BSX BNTX AMWL ALGN ABBV ZYXI Zynex $14.12 / -0.61 (-4.14%) 03/10/21 Largest borrow rate increases among liquid names SIOX Sio Gene Therapies $2.22 / +0.01 (+0.45%) 12/16/20 Unusually active option classes on open December 16th PACB Pacific Biosciences $25.68 / -0.1 (-0.39%) 04/29/21 Pacific Biosciences options imply 14.3% move in share price post-earnings 01/08/21 Pacific Biosciences call volume above normal and directionally bullish MRNA Moderna $169.25 / +5.16 (+3.14%) 05/03/21 Unusually active option classes on open May 3rd 04/16/21 Moderna call volume above normal and directionally bullish 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish EAR Eargo $32.10 / -1.12 (-3.37%) 01/20/21 Five new option listings on January 20th CVAC CureVac $115.64 / +1.27 (+1.11%) 05/25/21 Largest borrow rate increases among liquid names 05/10/21 Largest borrow rate increases among liquid names 05/06/21 Largest borrow rate increases among liquid names 04/26/21 Largest borrow rate increases among liquid names CLPT ClearPoint Neuro $18.07 / -0.38 (-2.06%) 03/15/21 Eight new option listings and one option delisting on March 15th BSX Boston Scientific $43.03 / +0.215 (+0.50%) 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish 04/28/21 Boston Scientific call volume above normal and directionally bullish 04/20/21 Boston Scientific call volume above normal and directionally bullish BNTX BioNTech $197.53 / +2.64 (+1.35%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names AMWL Amwell $11.89 / +0.38 (+3.30%) 04/09/21 American Well Corp call volume above normal and directionally bullish 03/24/21 American Well Corp options imply 12.3% move in share price post-earnings 12/15/20 American Well Corp put volume heavy and directionally bearish ALGN Align Technology $594.91 / -9.47 (-1.57%) 02/04/21 Early notable gainers among liquid option names on February 4th 02/03/21 Align Technology options imply 14.3% move in share price post-earnings ABBV AbbVie $114.56 / -1.35 (-1.16%) 03/17/21 Unusually active option classes on open March 17th 02/05/21 Unusually active option classes on open February 5th 01/27/21 AbbVie put volume heavy and directionally bearish
Hot Stocks	Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope » 06:56 05/25/21 05/25 06:56 05/25/21 06:56 BSX Boston Scientific $42.81 / +0.705 (+1.67%) Boston Scientific… Boston Scientific announced it has completed CE Mark for the EXALT Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the intensive care unit, operating room and bronchoscopy suite. Limited market release of the device is expected to commence in Europe in the coming weeks. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BSX Boston Scientific $42.81 / +0.705 (+1.67%) 05/21/21 FDA posts Class 1 device recall for Boston Scientific's VICI venous stent 05/10/21 BWX Technologies signs long-term agreement with Boston Scientific 03/29/21 McDonald's names Desiree Ralls-Morrison as General Counsel, Corporate Secretary 03/25/21 Boston Scientific reports 'positive' data from the TARGET study of TheraSphere BSX Boston Scientific $42.81 / +0.705 (+1.67%) 05/25/21 Barclays Barclays starts Medical Devices sector with Positive industry view 05/24/21 Barclays Boston Scientific initiated with an Overweight at Barclays 05/06/21 Raymond James Abiomed could face new competition from Boston Scientific, says Raymond James 04/29/21 Truist Boston Scientific price target raised to $50 from $42 at Truist BSX Boston Scientific $42.81 / +0.705 (+1.67%) 04/28/21 Boston Scientific sees FY21 adjusted EPS $1.53-$1.60, consensus $1.54 04/28/21 Boston Scientific sees Q2 EPS 36c-38c, consensus 35c 04/28/21 Boston Scientific reports Q1 EPS 37c, consensus 31c 04/27/21 Notable companies reporting before tomorrow's open BSX Boston Scientific $42.81 / +0.705 (+1.67%) 04/28/21 Fly Intel: Pre-market Movers 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 05/26/21 Global Healthcare Virtual Conference 2021 BSX Boston Scientific $42.81 / +0.705 (+1.67%) 05/24/21 Boston Scientific call volume above normal and directionally bullish 05/12/21 Boston Scientific put volume heavy and directionally bearish 04/28/21 Boston Scientific call volume above normal and directionally bullish 04/20/21 Boston Scientific call volume above normal and directionally bullish

On The Fly

News and insights, exclusive to thefly.com

09:57	Fly Intel: Top five analyst initiations»
09:57	Fly Intel: Top five analyst downgrades»
09:57	Fly Intel: Top five analyst upgrades»
09:46	Snap rallies after music, Lenses agreement with Universal Music Group»
07:22	Eli Lilly jumps on expedited plans for Alzheimer's drug, Biogen falls»

View all On The Fly Stories »

Upcoming
Events (10)

CVRX	CVRx - CVRX
CLVR	Clever Leaves - CLVR
TCOM	Trip.com Group - TCOM
OLED	Universal Display - OLED
	Policy Virtual Summit 2021
AMZN ...	Virtual ‘Bricks to Clicks’ Digital Conference
	Annual Virtual Meeting of EASL
	NextGen Payment & FinTech Virtual Forum
	HPE Virtual Discover 2021
APD	3rd Annual Hydrogen Virtual Conference

View all of today’s events »

Today’s
Syndicate (11)

BHG	IPO
CFLT	IPO
DOCS	IPO
GLUE	IPO
MIRO	IPO
SSR	IPO
AFCG	Secondary
BNL	Spot Secondary
OSW	Spot Secondary
PRTG	Spot Secondary
TALO	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial